Docking Station Peptide
Docking Station Peptide - Related Videos
10:25
Screening Traditional Chinese Medicine Compounds for Inhibiting UCHL3 Activity Based on Molecular Docking and Deubiquitinating Enzyme Probe Technology
0 Views •
2024
The experiment used here shows a method of molecular docking combined with probe technologies to predict and validate the interaction between small molecules of traditional Chinese medicine and protein targets.
04:00
Immunoaffinity Based Extraction of Ubiquitinylated Peptides: A Technique to Selectively Extract Ubiquitin Tagged Peptides from Purified Peptide Fractions
0 Views •
2023
This video describes a method to extract and purify ubiquitinylated peptides containing remnant di-glycine peptides from a complex peptide mixture. The presented method may help in identifying original ubiquitination sites in the protein.
08:49
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
0 Views •
Cited by 1 •
2025
Computational methods hold promises for expediting drug discovery, yet they frequently overlook the dynamic nature of protein structures. Here, we discuss ensemble-based docking analysis to indirectly incorporate protein flexibility, potentially improving the accuracy and reliability of drug discovery efforts.
03:21
Peptide Purification: An RP-HPLC-based Technique to Extract Peptides from Digested Protein Lysates
0 Views •
2023
In this video, we demonstrate reversed-phase high-performance liquid chromatography to purify peptides from a digested protein lysate mixture. These purified peptides are then lyophilized and stored for downstream applications. Analysis of peptides can help understand the mechanics involved in cellular signaling and cancer.
12:27
Measuring Peptide Translocation into Large Unilamellar Vesicles
0 Views •
Cited by 9 •
2012
This protocol details a method for the quantitative measure of peptide translocation into large unilamellar lipid vesicles. This method also provides information about the rate of membrane translocation and can be used to identify peptides that efficiently and spontaneously cross lipid bilayers.
FAQs
Selective recruitment arises from molecular recognition between the peptide and its intended binding partner. Complementary hydrogen bonding, electrostatic attraction, and hydrophobic association help favor particular interactions over nonspecific attachment. This selectivity allows engineered systems to gather chosen proteins, biomolecules, or synthetic components at defined locations rather than distributing them randomly.
The amino acid sequence influences which chemical interactions are available, while the three-dimensional structure determines how those interactions are presented to a binding partner. Together, they shape binding-site complementarity and positioning. Adjusting these features can tune how effectively a peptide organizes components for a particular bioengineering interface or assembly task.
Selective recognition depends on complementarity between a designed binding site and its partner, whereas nonspecific attachment does not require a defined molecular match. This distinction gives docking station systems greater control over which components are recruited and where they are positioned. Such control is especially relevant when organized assembly or a precise biological-engineered interface is required.
A general workflow begins by selecting or engineering a peptide sequence and structure suited to the intended binding partner. The peptide is then incorporated into a scaffold or related engineered platform so it can recruit and position components. Researchers can use the resulting arrangement to study molecular assembly or develop a more controlled biomaterial design.
These systems can organize molecular components in biosensors, drug-delivery systems, and tissue-engineering constructs. In each setting, the binding site provides a way to control recruitment and spatial arrangement within the engineered platform. Their tunability supports adaptable designs that connect biological molecules with synthetic materials or other engineered components.
Researchers can examine how biomolecular components assemble when their recruitment and positioning are deliberately controlled. The systems also support evaluation of modular biomaterial designs and interfaces between biological and engineered elements. By changing binding behavior, investigators can explore how molecular organization affects the usefulness and adaptability of biosensors, delivery platforms, or tissue-engineering constructs.